Prognostic value of texture analysis of the primary tumour in high-risk neuroblastoma: An 18 F-DOPA PET study

Pediatr Blood Cancer. 2022 Nov;69(11):e29910. doi: 10.1002/pbc.29910. Epub 2022 Aug 3.

Abstract

Purpose: To evaluate the prognostic value of texture analysis of the primary tumour with 18 fluorine-dihydroxyphenylalanine positron emission tomography/X-ray computed tomography (18 F-DOPA PET/CT) in patients affected by high-risk neuroblastoma (HR-NBL).

Methods: We retrospectively analysed 18 patients with HR-NBL, which had been prospectively enrolled in the course of a previous trial investigating the diagnostic role of 18 F-DOPA PET/CT at the time of the first onset. Texture analysis of the primary tumour was carried out on the PET images using LifeX. Conventional indices, histogram parameters, grey level co-occurrence (GLCM), run-length (GLRLM), neighbouring difference (NGLDM) and zone-length (GLZLM) matrices parameter were extracted; their values were compared with the overall metastatic load, expressed by means of whole-body metabolic burden (WBMB) score and the progression-free/overall survival (PFS and OS).

Results: There was a direct correlation between WBMB and radiomics parameter describing uptake intensity (SUVmean : p = .004) and voxel heterogeneity (entropy: p = .026; GLCM_Contrast: p = .001). Conversely, texture indices of homogeneity showed an inverse correlation with WBMB (energy: p = .026; GLCM_Homogeneity: p = .006). On the multivariate model, WBMB (p < .01) and the first standardised uptake value (SUV) quartile (p < .001) predicted PFS; OS was predicted by WBMB and the N-myc proto-oncogene protein (MYCN) amplification (p < .05) for both.

Conclusions: Textural parameters describing heterogeneity and metabolic intensity of the primary HR-NBL are closely associated with its overall metastatic burden. In turn, the whole-body tumour load appears to be one of the most relevant predictors of progression-free and overall survival.

Keywords: 18F-DOPA; PET; neuroblastoma; prognosis; radiomics.

MeSH terms

  • Dihydroxyphenylalanine / analogs & derivatives
  • Fluorine
  • Fluorodeoxyglucose F18
  • Humans
  • N-Myc Proto-Oncogene Protein
  • Neuroblastoma* / diagnostic imaging
  • Positron Emission Tomography Computed Tomography* / methods
  • Prognosis
  • Retrospective Studies

Substances

  • N-Myc Proto-Oncogene Protein
  • Fluorodeoxyglucose F18
  • Fluorine
  • fluorodopa F 18
  • Dihydroxyphenylalanine